PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of aapspharmspringer.comThis journalToc AlertsSubmit OnlineOpen Choice
 
AAPS PharmSciTech. 2005 March; 6(1): E9–E13.
Published online 2005 August 10. doi:  10.1208/pt060104
PMCID: PMC2750405

Bioavailability assessment of ketoprofen incorporated in gelled self-emulsifying formulation: A technical note

Conclusion

Based on the results of the present study, it is apparent that the gelled SEF containing KPF did not significantly alter its bioavailability as compared with that of an immediate release solid dosage form when administered to human volunteers by the oral route.

Full Text

The Full Text of this article is available as a PDF (100K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
1. Charman SA, Charman WN, Rogge MC, Wilson TD, Pouton CW. Self-emulsifying drug delivery systems: formulation and biopharmaceutical evaluation of an investigational lipophilic compound. Pharm Res. 1992;9:87–93. doi: 10.1023/A:1018987928936. [PubMed] [Cross Ref]
2. Itoh K, Tozuka Y, Oguchi T, Yamamoto K. Improvement of physicochemical properties of N-4472 part I formulation design by using self-microemulsifying system. Int J Pharm. 2002;238:153–160. [PubMed]
3. Kim H-J, Yoon KA, Hahn M, Park E-S, Chi S-C. Preparation and in vitro evaluation of self-microemulsifying drug delivery systems containing idebenone. Drug Dev Ind Pharm. 2000;26:523–529. doi: 10.1081/DDC-100101263. [PubMed] [Cross Ref]
4. Kommuru TR, Gurley B, Khan MA, Reddy IK. Self-emulsifying drug deliverly systems (SEDDS) of coenzyme Q10: formulation development and bioavailability assessment. Int J Pharm. 2001;212:233–246. doi: 10.1016/S0378-5173(00)00614-1. [PubMed] [Cross Ref]
5. Khoo S-M, Humberstone AJ, Porter CJH, Edwards GA, Charman WN. Formulation design and bioavailability assessment of lipidic self-emulsifying formulations of halofantrine. Int J Pharm. 1998;167:155–164. doi: 10.1016/S0378-5173(98)00054-4. [Cross Ref]
6. Gao ZG, Choi HG, Shin HJ, et al. Physicochemical characterization and evaluation of a microemulsion system for oral delivery of cyclosporine A. Int J Pharm. 1998;167:75–86. doi: 10.1016/S0378-5173(97)00325-6. [Cross Ref]
7. Physician's Desk Reference. 56th ed. Montvale, NJ: Medical Economic Company; 2002.
8. Anderson T, Bredberg E, Lagerstrom PO, Naesdal J, Wilson I. Lack of drug-drug interaction between three different non-steroidal anti-inflammatory drugs and omeprazole. Eur J Clin Pharmacol. 1998;54:399–404. doi: 10.1007/s002280050482. [PubMed] [Cross Ref]
9. Upton RA, Williams RL, Guentert TW, Buskin JN, Reigelman S. Ketoprofen pharmacokinetics and bioavailability based on an improved sensitive and specific assay. Eur J Clin Pharmacol. 1981;20:123–127. doi: 10.1007/BF00607149. [PubMed] [Cross Ref]
10. Bannwarth B, Lapieque F, Netter P, et al. The effect of food on the systemic availability of ketoprofen. Eur J Clin Pharmacol. 1988;33:643–645. doi: 10.1007/BF00542503. [PubMed] [Cross Ref]
11. Vergote GJ, Vervaet C, Driessche I, et al. An oral controlled release matrix pellet formulation containing nanocrystalline ketoprofen. Int J Pharm. 2001;219:81–87. doi: 10.1016/S0378-5173(01)00628-7. [PubMed] [Cross Ref]
12. Yamada T, Onishi H, Machida Y. Sustained release ketoprofen microparticles with ethylcellulose and carboxymethylethylcellulose. J Control Release. 2001;219:271–282. doi: 10.1016/S0168-3659(01)00399-6. [PubMed] [Cross Ref]
13. El-Kamel AH, Sokar MS, Gamal SS, Naggar VF. Preparation and evaluation of ketoprofen floating oral delivery system. Int J Pharm. 2001;219:13–21. doi: 10.1016/S0378-5173(01)00574-9. [PubMed] [Cross Ref]
14. Gershanik T, Benita S. Self-dispersing lipid formulations for improving oral absorption of lipophilic drugs. Eur J Pharm Biopharm. 2000;50:179–188. doi: 10.1016/S0939-6411(00)00089-8. [PubMed] [Cross Ref]
15. MacGregor KJ, Embleton JK, Lacy JE, et al. Influence of lipolysis on drug absorption from gastro-intestinal tract. Adv Drug Deliv Rev. 1997;50:33–46. doi: 10.1016/S0169-409X(96)00489-9. [Cross Ref]
16. Humberstone AJ, Charmann WN. Lipid-based vehicles for the oral delivery of poorly water-soluble drugs. Adv Drug Deliv Rev. 1997;25:103–128. doi: 10.1016/S0169-409X(96)00494-2. [Cross Ref]
17. Patil P, Joshi P, Paradkar A. Effect of formulation variables on preparation and evaluation of gelled self-emulsifying drug delivery system (SEDDS) of ketoprofen. AAPS PharmSci Tech. 2004;5:E42–E42. doi: 10.1208/pt050342. [PMC free article] [PubMed] [Cross Ref]
18. Satterwhite JH, Boudinot DF. High-performance liquid chromatographic determination of ketoprofen and naproxen in rat plasma. J Chromatogr. 1998;25:444–449. [PubMed]
19. Gibaldi M, Perrier D. Pharmacokinetics. 2nd ed. New York, NY: Marcel Dekker; 1982. pp. 145–149.
20. FDA/CDER Guidance Document page. Bioavailability and bioequivalence studies for orally administered drug products-general considerations. Food and Drug Administration Web site. Available at: http://www.fda.gov/cder/guidance. Accessed October 2002.
21. Raghavan SR, Walls HJ, Khan SA. Rheology of silica dispersions in organic liquids: new evidence for salvation forces dictated by hydrogen bonding. Langmuir. 2000;16:7920–7930. doi: 10.1021/la991548q. [Cross Ref]
22. Nerurkar MM, Burton PS, Borchardt RT. The use of surfactants to enhance the permeability of peptides through Caco 2 cells by inhibition of an apically polarized efflux system. Pharm Res. 1996;13:528–534. doi: 10.1023/A:1016033702220. [PubMed] [Cross Ref]

Articles from AAPS PharmSciTech are provided here courtesy of American Association of Pharmaceutical Scientists